What is the primary purpose of implantable contact lenses (IPCLs) as described in the survey?

Implantable contact lenses (IPCLs) are a treatment method used to correct myopia and astigmatism by inserting a small lens into the eye.

What material is primarily used in the construction of IPCLs, and where else is this material commonly found?

IPCLs primarily use an acrylic polymer material composed of HEMA, which is also widely used in intraocular lenses for cataracts and standard contact lenses.

How does the reversibility of IPCLs compare to LASIK, according to the article?

Unlike LASIK, which involves shaving the cornea, IPCLs are considered a highly reversible treatment because the implanted lens can be removed in the future.

When did IPCLs receive regulatory approval and launch in Japan, as stated in the article?

IPCLs obtained regulatory approval from the Ministry of Health, Labour and Welfare in April 2025 and were launched in September of the same year in Japan.

What percentage of survey respondents were aware of implantable contact lenses as a treatment method?

More than 70% of the survey subjects, specifically 72.8%, were aware of implantable contact lenses as a treatment method.

AI News NQ Analysis

Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less

NQ Score 59/100

Key facts

Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less
At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.
Date: Mon Mar 30 2026 11:04:50 GMT+0900 (Japan Standard Time)

Direct answer

At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.

Citation: Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less (Mon Mar 30 2026 11:04:50 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon Mar 30 2026 11:04:50 GMT+0900 (Japan Standard Time)

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the primary purpose of implantable contact lenses (IPCLs) as described in the survey?: A: Implantable contact lenses (IPCLs) are a treatment method used to correct myopia and astigmatism by inserting a small lens into the eye.
Q: What material is primarily used in the construction of IPCLs, and where else is this material commonly found?: A: IPCLs primarily use an acrylic polymer material composed of HEMA, which is also widely used in intraocular lenses for cataracts and standard contact lenses.
Q: How does the reversibility of IPCLs compare to LASIK, according to the article?: A: Unlike LASIK, which involves shaving the cornea, IPCLs are considered a highly reversible treatment because the implanted lens can be removed in the future.
Q: When did IPCLs receive regulatory approval and launch in Japan, as stated in the article?: A: IPCLs obtained regulatory approval from the Ministry of Health, Labour and Welfare in April 2025 and were launched in September of the same year in Japan.
Q: What percentage of survey respondents were aware of implantable contact lenses as a treatment method?: A: More than 70% of the survey subjects, specifically 72.8%, were aware of implantable contact lenses as a treatment method.